CLINICAL_TRIALS
trial_result
· 2021-06-15
Clinical Trial Update: A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis [Phase 2]
Summary
Phase 2 trial of repeat dosing with Squaric Acid Dibutyl Ester for herpes labialis was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Squarex, LLC | Conditions: Herpes Labialis, HSV | Phase 2 | Status: TERMINATED | Results posted: 2021-06-15